Richard Marshak
Corporate Officer/Principal presso TRISALUS LIFE SCIENCES, INC.
Patrimonio netto: 195 117 $ in data 31/05/2024
Profilo
Richard B.
Marshak is the founder of Nephraegis Therapeutics, Inc. (founded in 2018) where he holds the title of Director & Chief Business Officer.
He is currently working as Senior VP-Corporate Development & Strategy at TriSalus Life Sciences, Inc. since 2023.
Previously, Richard served as the Chief Executive Officer & Director at Mount TAM Biotechnologies, Inc. from 2016 to 2019.
He also worked at Abbott Laboratories as the General Manager-Alliance Management from 1999 to 2013.
Additionally, Richard was the President & Principal at LF Consulting from 2013 to 2022.
Dr. Marshak completed his undergraduate degree at the University of Pennsylvania and holds an MBA from The University of Chicago Booth School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 12/02/2024 | 27 251 ( 0.10% ) | 195 117 $ | 31/05/2024 |
Posizioni attive di Richard Marshak
| Società | Posizione | Inizio |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Corporate Officer/Principal | 10/08/2023 |
Nephraegis Therapeutics, Inc.
 Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nephraegis Therapeutics is a biopharmaceutical company based in Lake Forest, IL. Nephraegis Therapeutics, Inc. focuses on targeting acute kidney injury (AKI) through the development of a family of proprietary drug candidates. The company's lead compound, NPH-022, is an epoxyeicosatrienoic-related compound (EET) with optimized pharmacokinetic properties. The company was founded by Richard B. Marshak, and Bryan F. Cox has been the CEO since 2018. | Fondatore | 01/09/2018 |
Precedenti posizioni note di Richard Marshak
| Società | Posizione | Fine |
|---|---|---|
LF Consulting
 LF Consulting Miscellaneous Commercial ServicesCommercial Services LF Consulting specializes in data management and analysis. The private company is based in Sherwood, OR. The company's services include obtaining, transforming, processing, and visualizing data to help clients make informed decisions. | Presidente | 01/06/2022 |
Mount TAM Biotechnologies, Inc.
 Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Amministratore Delegato | 01/10/2019 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2013 |
Formazione di Richard Marshak
| University of Pennsylvania | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| TRISALUS LIFE SCIENCES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Mount TAM Biotechnologies, Inc.
Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Health Technology |
LF Consulting
LF Consulting Miscellaneous Commercial ServicesCommercial Services LF Consulting specializes in data management and analysis. The private company is based in Sherwood, OR. The company's services include obtaining, transforming, processing, and visualizing data to help clients make informed decisions. | Commercial Services |
Nephraegis Therapeutics, Inc.
Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nephraegis Therapeutics is a biopharmaceutical company based in Lake Forest, IL. Nephraegis Therapeutics, Inc. focuses on targeting acute kidney injury (AKI) through the development of a family of proprietary drug candidates. The company's lead compound, NPH-022, is an epoxyeicosatrienoic-related compound (EET) with optimized pharmacokinetic properties. The company was founded by Richard B. Marshak, and Bryan F. Cox has been the CEO since 2018. | Health Technology |
- Borsa valori
- Insiders
- Richard Marshak
